Activating P2X7 Receptors Increases Proliferation of Human Pancreatic Cancer Cells via ERK1/2 and JNK
Activating P2X7 Receptors Increases Proliferation of Human Pancreatic Cancer Cells via ERK1/2 and JNK
复制标题
DOI:
10.1097/mpa.0000000000001055
复制
发表时间:
2018-05-01
期刊:
影响因子:
2.9
通讯作者:
Lee, Dong Hyeon
中科院分区:
文献类型:
--
作者:
Choi, Ji Hun;Ji, Young Geon;Lee, Dong Hyeon
Objectives The aim of this study was to investigate the effects of the activated P2X(7) receptors on the proliferation and growth of human pancreatic cancer cells.Methods Proliferation was measured by incorporating bromodeoxyuridine into pancreatic cancer cells, MIA PaCa-2 and HPAC. Expression of P2 receptors and signal molecules was examined using quantitative reverse transcription/polymerase chain reaction and/or Western blot. Proliferative effects of the P2X(7) receptors in vivo were examined using a xenotransplant model of pancreatic cancer cell lines.Results Incubating pancreatic cancer cells with adenosine triphosphate (ATP) and 2(3)-O-(4-Benzoylbenzoyl)ATP resulted in a dose-dependent increase of cell proliferation. The P2 receptor antagonist, KN-62, and small interfering RNA against P2X(7) receptors, significantly decreased the proliferative effects of ATP. The ATP-induced proliferation was mediated by protein kinase C, extracellular signal-regulated protein kinases 1 and 2 (ERK1/2), and c-Jun N-terminal kinase (JNK); specifically, ATP increased the phosphorylation of ERK1/2 and JNK. The expression of inducible nitric oxide synthase was decreased by P2X(7) receptor activation. In a xenotransplant model, applying ATP significantly increased the growth of induced tumors.Conclusions The P2X(7) receptor activation by extracellular nucleotides increased proliferation and growth of human pancreatic cancer cells via ERK1/2 and JNK. This supports the pathophysiological role of P2X(7) receptors in pancreatic disease and recovery.